HEFAVAY Trademark

Trademark Overview


On Thursday, September 1, 2016, a trademark application was filed for HEFAVAY with the United States Patent and Trademark Office. The USPTO has given the HEFAVAY trademark a serial number of 87157919. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 7, 2025. This trademark is owned by Glaxo Group Limited. The HEFAVAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
hefavay

General Information


Serial Number87157919
Word MarkHEFAVAY
Filing DateThursday, September 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 7, 2025
Registration Number5543425
Registration DateTuesday, August 21, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Translation of Words in MarkThe wording "HEFAVAY" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 7, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Wednesday, June 28, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, September 5, 2016NEW APPLICATION ENTERED
Wednesday, September 7, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2016ASSIGNED TO EXAMINER
Monday, December 12, 2016SUSPENSION LETTER WRITTEN
Monday, December 12, 2016LETTER OF SUSPENSION E-MAILED
Monday, December 12, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 8, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, June 28, 2017SUSPENSION INQUIRY WRITTEN
Wednesday, June 28, 2017INQUIRY TO SUSPENSION E-MAILED
Tuesday, December 12, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, August 13, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 29, 2017ASSIGNED TO LIE
Tuesday, August 29, 2017ASSIGNED TO LIE
Thursday, August 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 27, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 17, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, June 8, 2018NOTICE OF ALLOWANCE CANCELLED
Tuesday, July 10, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 21, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 8, 2018TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 17, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 7, 2025CANCELLED SEC. 8 (6-YR)
Monday, August 21, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED